# US 2013/0158442 A1 · Methods for thermally-induced renal neuromodulation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0158442 A1
- Document ID: US20130158442A1
- Status: Published application
- Kind: A1
- Application number: 13/765,532
- Filed: 2013-02-12
- Published: 2013-06-20
- Earliest claimed: 2002-04-08
- Assignees: Ardian, Inc.
- Inventors: Denise Demarais; Nicolas Zadno; Benjamin J. Clark; Erik Thai; Howard R. Levin; Mark Gelfand
- Web page: https://patentgrep.com/patent/US20130158442A1

## CPC

- A61N 7/022: {intracavitary}
- A61B 18/02: by cooling, e.g. cryogenic techniques
- A61B 18/04: by heating (by applying electromagnetic radiation A61B18/18)
- A61B 18/12: by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B 18/1492: {having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence)}
- A61F 7/007: {characterised by electric heating}
- A61F 7/12: Devices for heating or cooling internal body cavities
- A61F 7/123: {using a flexible balloon containing the thermal element}
- A61M 5/44: having means for cooling or heating the devices or media
- A61N 1/28: Apparatus for applying thermoelectric currents
- A61N 1/403: {for thermotherapy, e.g. hyperthermia}
- A61N 5/00: Radiation therapy (ultrasound therapy A61N7/00; devices or apparatus applicable to both therapy and diagnosis A61B6/00)
- A61N 5/025: {Warming the body, e.g. hyperthermia treatment}
- A61N 5/045: {specially adapted for treatment inside the body}
- A61N 5/0603: {for treatment of body cavities}
- A61N 7/00: Ultrasound therapy (lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 {; using ultrasound for introducing media into the body A61M37/0092})
- A61N 7/02: Localised ultrasound hyperthermia
- A61B 2018/0022: {Balloons}
- A61B 2018/00434: {Neural system}
- A61B 2018/00511: {Kidney}
- A61B 2018/00577: {Ablation}
- A61F 2007/126: {for invasive application, e.g. for introducing into blood vessels}
- A61M 2210/1082: Kidney
- A61N 1/36007: {of urogenital or gastrointestinal organs, e.g. for incontinence control}
- A61N 2007/003: {Destruction of nerve tissue}
- A61N 2007/0078: {with multiple treatment transducers}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Methods and apparatus are provided for thermally-induced renal neuromodulation. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers. In some embodiments, parameters of the neural fibers, of non-target tissue, or of the thermal energy delivery element, may be monitored via one or more sensors for controlling the thermally-induced neuromodulation. In some embodiments, protective elements may be provided to reduce a degree of thermal damage induced in the non-target tissues.

## Claims

### Claim 1

A method of treating a human patient diagnosed with a cardio-renal disease or disorder, the method comprising:
intravascularly delivering a device to a vicinity of a neural fiber associated with renal function of the patient; and
thermally inhibiting neural communication along the neural fiber with the device.

### Claim 2 (depends on 1)

The method of claim 1 wherein thermally inhibiting neural communication along the neural fiber with the device comprises thermally inhibiting afferent neural communication along the neural fiber with the device.

### Claim 3 (depends on 1)

The method of claim 1 wherein thermally inhibiting neural communication along the neural fiber with the device comprises thermally inhibiting efferent neural communication along the neural fiber with the device.

### Claim 4 (depends on 1)

The method of claim 1 wherein intravascularly delivering a device to a vicinity of a neural fiber associated with renal function comprises intravascularly delivering the device via a renal blood vessel to a position proximate to the neural fiber.

### Claim 5 (depends on 1)

The method of claim 1 wherein intravascularly delivering the device via a blood vessel to a position proximate to the neural fiber comprises intravascularly positioning the device in contact with a wall of the blood vessel proximate to the neural fiber.

### Claim 6 (depends on 1)

The method of claim 1 wherein thermally inhibiting neural communication along the neural fiber with the device comprises at least partially ablating the neural fiber with the device.

### Claim 7 (depends on 1)

The method of claim 1 wherein thermally inhibiting neural communication along the neural fiber with the device comprises thermally altering the neural fiber using at least one of non-ablative heating, ablative heating, cooling, and freezing.

### Claim 8 (depends on 1)

The method of claim 1, further comprising removing the device from the patient after thermally inhibiting neural communication along the neural fiber.

### Claim 9 (depends on 1)

The method of claim 1 wherein thermally inhibiting neural communication along the neural fiber with the device comprises delivering an energy field to the neural fiber via the device.

### Claim 10 (depends on 9)

The method of claim 9 wherein delivering an energy field to the neural fiber via the device comprises delivering radiofrequency energy via the device.

### Claim 11 (depends on 9)

The method of claim 9 wherein delivering an energy field to the neural fiber via the device comprises delivering microwave energy via the device.

### Claim 12 (depends on 9)

The method of claim 9 wherein delivering an energy field to the neural fiber via the device comprises delivering ultrasound energy via the device.

### Claim 13 (depends on 12)

The method of claim 12 wherein delivering ultrasound energy via the device comprises delivering high intensity focused ultrasound energy via the device.

### Claim 14 (depends on 9)

The method of claim 9 wherein delivering an energy field to the neural fiber via the device comprises delivering laser energy via the device.

### Claim 15 (depends on 1)

The method of claim 1 wherein thermally inhibiting neural communication along the neural fiber with the device comprises reducing neural activity via cooling the neural fiber.

### Claim 16 (depends on 1)

The method of claim 1 wherein thermally inhibiting neural communication along the neural fiber with the device comprises causing freezing injury to the neural fiber.

### Claim 17 (depends on 1)

The method of claim 1 wherein thermally inhibiting neural communication along the neural fiber with the device comprises delivering a thermal fluid via the device.

### Claim 18

A method of treating a human patient diagnosed with a medical condition, the method comprising:
positioning a device in proximity to a neural pathway that carries nerve signals to and from a kidney of the patient; and
thermally inhibiting the nerve signals across the neural pathway with the device,
wherein thermally inhibiting the nerve signals across the neural pathway results in a therapeutically beneficial reduction in renal sympathetic nerve activity of the patient.

### Claim 19 (depends on 18)

The method of claim 18 wherein treating a human patient diagnosed with a medical condition comprises treating a human patient diagnosed with hypertension.

### Claim 20 (depends on 18)

The method of claim 18 wherein treating a human patient diagnosed with a medical condition comprises treating a human patient diagnosed with chronic heart failure.

### Claim 21 (depends on 18)

The method of claim 18 wherein treating a human patient diagnosed with a medical condition comprises treating a human patient diagnosed with a condition associated with diabetes.

### Claim 22 (depends on 18)

The method of claim 18 wherein treating a human patient diagnosed with a medical condition comprises treating a human patient diagnosed with kidney disease.

### Claim 23 (depends on 18)

The method of claim 18 wherein treating a human patient diagnosed with a medical condition comprises treating a human patient diagnosed with chronic renal failure.

### Claim 24 (depends on 18)

The method of claim 18 wherein treating a human patient diagnosed with a medical condition comprises treating a human patient diagnosed with acute myocardial infarction.

### Claim 25 (depends on 18)

The method of claim 18 wherein treating a human patient diagnosed with a medical condition comprises treating a human patient diagnosed with atrial fibrillation.
